Lilly Pharmaceuticals: Our company's treatment for lymphocytic leukemia, Jaypirca, has been approved by the FDA
芊芊551
发表于 2023-12-2 09:57:12
214
0
0
Lilly Pharmaceuticals claims that its treatment for lymphocytic leukemia, Jaypirca (pirobrutinib/pirobrutinib), has been approved by the US Food and Drug Administration (FDA).
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。